EMPIRICO
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.The company's platform uses biological datasets, human genetics, and programmable biology to power target discovery and development, enabling scientists to systematically generate, interrogate, and prioritize high-confidence therapeutic hypotheses.
EMPIRICO
Industry:
Biotechnology Medical
Founded:
2017-11-07
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.empiricotx.com
Total Employee:
11+
Status:
Active
Contact:
347-725-0022
Total Funding:
29.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
BrickBio
BrickBio is a developer of a bioconjugation platform intended for research of site-specific modification of proteins.
Dice Therapeutics
Dice Therapeutics develops a transformative platform designed for the discovery of novel small molecules.
Opsonix
Opsonix is a developer of a pathogen-extracting therapy designed to transform the treatment of bloodstream infections and sepsis.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Employees Featured
Omri Gottesman CEO @ Empirico
CEO
2018-01-01
John Vekich Associate Director @ Empirico
Associate Director
David Rozema Head of Therapeutic Chemistry @ Empirico
Head of Therapeutic Chemistry
Andrew Spencer Head of Strategy @ Empirico
Head of Strategy
Anggie Becorest Head of Operations @ Empirico
Head of Operations
2018-12-01
Brian Cajes Head of Data and Engineerin & Co-Founder @ Empirico
Head of Data and Engineerin & Co-Founder
2018-01-01
Shannon Bruse Head of Discovery @ Empirico
Head of Discovery
David Lewis Head of Therapeutic Development @ Empirico
Head of Therapeutic Development
2018-11-01
PJ Buske Director @ Empirico
Director
Founder
Investors List
DCVC Bio
DCVC Bio investment in Series A - Empirico
Ionis Pharmaceuticals
Ionis Pharmaceuticals investment in Series A - Empirico
Neotribe Ventures
Neotribe Ventures investment in Series A - Empirico
DCVC Bio
DCVC Bio investment in Series A - Empirico
Neotribe Ventures
Neotribe Ventures investment in Series A - Empirico
Official Site Inspections
http://www.empiricotx.com
- Host name: server-3-167-37-99.iad61.r.cloudfront.net
- IP address: 3.167.37.99
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Empirico"
Empirico
Empowered by our foundational technology platforms, Empirico is discovering and developing novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease.See details»
Our company - Empirico
In pursuit of this goal, we have built an efficient and integrated drug discovery organization, with fully-internal capabilities spanning computational target discovery, in vitro and in vivo target …See details»
Empirico - Crunchbase Company Profile & Funding
Empirico may be growing as it has recently secured a significant amount of funding, which is a strong indicator of investor confidence and financial resources for expansion.See details»
Empirico - Products, Competitors, Financials, Employees, …
Empirico is advancing multiple programs across a broad range of indications and therapeutic modalities, both independently and in collaboration with industry partners. Empirico is …See details»
Empirico Company Profile - Craft
Empirico $29.5 m in total funding,. See insights on Empirico including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Empirico Inc. - edgein.io
Empirico is a venture-backed, next-generation therapeutics company founded on utilizing huge biological data sets, human genetics and programmable biology to power novel target …See details»
AbCellera Biologics Inc. - AbCellera and Empirico Expand Strategic ...
May 3, 2022 To learn more about Empirico, visit www.empiricotx.com. About AbCellera Biologics Inc. AbCellera is a technology company that searches, decodes, and analyzes …See details»
Investors & news - Empirico
Jan 9, 2020 Contact: media@empiricotx.com. View all Press Releases Tue May 3, 2022 AbCellera and Empirico Expand Strategic Multi-Target Antibody Discovery Collaboration Collaboration expanded from five to seven targets …See details»
Empirico Inc. | Insights
Apr 21, 2021 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Empirico - Work in biotech
Empirico is using human genetics to create next-generation therapeutics. With advances in DNA sequencing, human genetics can now be employed to gain new biological insights for …See details»
Empirico, Inc. (Empirico, Inc.) - 药物管线_专利_临床试验_投融营收_ …
了解Empirico, Inc. (Empirico, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 3篇新闻和1篇文献，疾病领域:神经系统疾病，内分泌与代谢疾病，免疫系统疾病，技术平 …See details»
Empirico Inc | CipherBio
Explore Empirico Inc's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Terms of Use - Empirico
Dec 22, 2023 If you are accessing the Site on behalf of an entity, organization, or Empirico, then (a) “you” will refer to that entity, organization, or Empirico, and (b) the individual accessing or …See details»
Empirico Announces Strategic Collaboration to Harness Human …
Jan 9, 2020 To learn more about Empirico, visit www.empiricotx.com. Contacts. Media Contact: Jessica Yingling Ph.D. Little Dog Communications Inc. jessica@litldog.com +1-858-344-8091See details»
Empirico, Inc. · GitHub
Empirico, Inc. has 2 repositories available. Follow their code on GitHub.See details»
Empirico Inc. Email Format | empiricotx.com Emails
The most common Empirico Inc. email format is [first].[last] (ex. jane.doe@empiricotx.com), which is being used by 93.9% of Empirico Inc. work email addresses. Other common Empirico Inc. …See details»
AbCellera and Empirico Expand Strategic Multi-Target Antibody …
Empirico is advancing multiple programs across a broad range of indications and therapeutic modalities, both independently and in collaboration with industry partners. Empirico is …See details»
Cancer | EMPIRI | Houston
Empirical drug sensitivity data will accelerate the developent of new cancer therapies, increasing clinical effectiveness and reducing costly side effects and overall healthcare costs.See details»
Careers - Empirico
Position Description: Empirico, a clinical-stage biotechnology company that combines unmatched expertise in human genetics-driven target discovery with world-class capabilities in siRNA …See details»
Empirico Announces Strategic Collaboration to Harness Human …
SAN DIEGO, January 9, 2020 — Empirico Inc. announced today that it has entered into a strategic collaboration with Ionis Pharmaceuticals. During the three-year collaboration, …See details»